Status:
UNKNOWN
Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms
Lead Sponsor:
Mansoura University
Conditions:
Ureteral Stent
Stent Related Symptoms
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The primary objective of this prospective, single-centre randomized controlled trial is to assess the efficacy of three different drugs in treatment of ureteral stents related symptoms (Beta 3 adrener...
Detailed Description
Indwelling ureteral stents are specialized catheters designed to alleviate obstruction by maintaining the patency of the ureteral lumen and to splint the ureter by acting as a scaffold to promote orga...
Eligibility Criteria
Inclusion
- Adult patients (aged 19-80 years)
- Undergo unilateral uncomplicated retrograde rigid ureteroscopy (URS) or retrograde intrarenal surgery (RIRS) with planned ureteral stent insertion.
Exclusion
- Patients with neurogenic bladder, OAB syndrome, and neurological and psychiatric diseases
- Residual ureteral or renal stones after the procedure
- Preoperative febrile UTI
- pregnancy or breastfeeding
- Bilateral ureteroscopic surgery
- Single kidney
- Chronic kidney disease
- Cardiovascular or cerebrovascular disease
- Hepatic dysfunction
- History of pelvic surgery or irradiation
- History of bladder or prostate surgery
- Other acute medical conditions as acute gastroenteritis, osetoarthritis that might influence the patient QoL
- Preoperative indwelling of ureteral stent for relief of stone-related pain or sepsis
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04325880
Start Date
December 1 2021
End Date
July 1 2022
Last Update
November 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and Nephrology Center
Al Mansurah, DK, Egypt, 35516